RNA-Seq Analysis of Clinical Samples from TCGA Reveal Molecular Signatures for Ovarian Cancer

Referencess

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics. CA Cancer J Clin. 2018;68(4):284–296. doi:10.3322/caac.21456.
   PubMed Web of Science ®Google Scholar
• Peres LC, Cushing-Haugen KL, Köbel M, Harris HR, Berchuck A, Rossing MA, et al. Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst. 2019;111:60–68. doi:10.1093/jnci/djy071.
   PubMedGoogle Scholar
• Odunsi K. Immunotherapy in ovarian cancer. Ann Oncol. 2017;28(suppl_8):viii1–viii7. doi:10.1093/annonc/mdx444.
   PubMedGoogle Scholar
• Smetana K, Lacina L, Szabo P, Dvořánková B, Brož P, Šedo A. Ageing as an important risk factor for cancer. Anticancer Res. 2016;36(10):5009–5017. doi:10.21873/anticanres.11069.
   PubMed Web of Science ®Google Scholar
• Atallah GA, Abd Aziz NH, Teik CK, Shafiee MN, Kampan NC. New predictive biomarkers for ovarian cancer. Diagnostics. 2021;11(3):465. doi:10.3390/diagnostics11030465.
   Web of Science ®Google Scholar
• Chen J, Cai Y, Xu R, Pan J, Zhou J, Mei J. Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico. Cancer Cell Int. 2020;20:270. doi:10.1186/s12935-020-01361-1.
   PubMed Web of Science ®Google Scholar
• Wu L, Shang W, Zhao H, Rong G, Zhang Y, Xu T, et al. In silico screening of circulating microRNAs as potential biomarkers for the diagnosis of ovarian cancer. Dis Markers. 2019;2019:7541857. doi:10.1155/2019/7541857.
   PubMed Web of Science ®Google Scholar
• Wadapurkar RM, Sivaram A, Vyas R. Computational studies reveal co-occurrence of two mutations in IL7R gene of high-grade serous carcinoma patients. J Biomol Struct Dyn. 2021;16:1–15.
   Google Scholar
• Huo X, Sun H, Liu S, Liang B, Bai H, Wang S, Li S. Identification of a prognostic signature for ovarian cancer based on the microenvironment genes. Front Genet. 2021;13:12–680413.
   Google Scholar
• Ni L, Chen Y, Yang J, Chen C. Bioinformatic analysis of key pathways and genes shared between endometriosis and ovarian cancer. Arch Gynecol Obstet. 2021;305(5):1329–1342. doi:10.1007/s00404-021-06285-3.
   Web of Science ®Google Scholar
• Zhang J, Xiang Y, Ding L, Keen-Circle K, Borlawsky TB, Ozer HG, et al. Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia. BMC Bioinf. 2010;11 :S5. doi:10.1186/1471-2105-11-S9-S5.
   PubMed Web of Science ®Google Scholar
• Wolf DM, Lenburg ME, Yau C, Boudreau A, van ‘T Veer LJ. Gene co expression modules as clinically relevant hallmarks of breast cancer diversity. PLOS One. 2014;9(2):e88309. doi:10.1371/journal.pone.0088309.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liu Y, Li K, Zhang R, Qiu F, Zhao N, Xu Y. ICan: an integrated co-alteration network to identify ovarian cancer-related genes. PLOS One. 2015;10(3):e0116095. doi:10.1371/journal.pone.0116095.
   PubMed Web of Science ®Google Scholar
• Gov E, Arga KY. Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer. Sci Rep. 2017;7(1):4996. doi:10.1038/s41598-017-05298-w.
   PubMedGoogle Scholar
• Kumar R, Sakthive S, Kumar Verma R, Bhanti P, Sharma P, Gaur RK. Differential expression analysis of prostate cancer-responsive genes and miRNAs as useful biomarkers. Arctic Journal. 2018;71(2)
   Google Scholar
• Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R/bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71–e71. 7. doi:10.1093/nar/gkv1507.
   Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26 (1):139–140. doi:10.1093/bioinformatics/btp616.
   PubMed Web of Science ®Google Scholar
• Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27:431–432.
   PubMed Web of Science ®Google Scholar
• Su G, & Morris J, & Demchak B, Bader G. Biological network exploration with Cytoscape 3. Curr Protoc Bioinformat. 2014;47:8.13.1–24. doi:10.1002/0471250953.bi0813s47.
   PubMedGoogle Scholar
• Zhang Y, Qazi S, Raza K. Differential expression analysis in ovarian cancer: a functional genomics and systems biology approach. Saudi J Biol Sci. 2021;28(7):4069–4081. doi:10.1016/j.sjbs.2021.04.022.
   PubMed Web of Science ®Google Scholar
• Sharan R, Ulitsky I, Shamir R. Network-based prediction of protein function. Mol Syst Biol. 2007;3:88. doi:10.1038/msb4100129.
   PubMed Web of Science ®Google Scholar
• Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinf. 2003;4:2.
   PubMed Web of Science ®Google Scholar
• Udhaya Kumar S, Thirumal Kumar D, Bithia R, Sankar S, Magesh R, Sidenna M, et al. Analysis of differentially expressed genes and molecular pathways in familial hypercholesterolemia involved in atherosclerosis: a systematic and bioinformatics approach. Front Genet. 2020;11:734.
   PubMed Web of Science ®Google Scholar
• Assenov Y, Ramírez F, Schelhorn SE, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008;24(2):282–284. doi:10.1093/bioinformatics/btm554.
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. CytoHubba: identifying hub objects and sub networks from complex interactome. BMC Syst Biol. 2014;8:S11. doi:10.1186/1752-0509-8-S4-S11.
   PubMed Web of Science ®Google Scholar
• Karagoz K, Sinha R, Arga KY. Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways. OMICS. 2015;19(2):115–130. doi:10.1089/omi.2014.0135.
   PubMed Web of Science ®Google Scholar
• Kori M, Gov E, Arga KY. Molecular signatures of ovarian diseases: insights from network medicine perspective. Syst Biol Reprod Med. 2016;62(4):266–282. doi:10.1080/19396368.2016.1197982.
   PubMed Web of Science ®Google Scholar
• Gui T, Yao C, Jia B, Shen K. Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods. PLOS One. 2021;16(6):e0253136. doi:10.1371/journal.pone.0253136.
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–13. doi:10.1093/nar/gkn923.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao GE, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247.
   PubMed Web of Science ®Google Scholar
• Kuksin M, Morel D, Aglave M, Danlos F-X, Marabelle A, Zinovyev A, et al. Applications of single-cell and bulk RNA-sequencing in onco-immunology. Eur J Cancer. 2021;149:193–210. doi:10.1016/j.ejca.2021.03.005.
   PubMed Web of Science ®Google Scholar
• Francone E, Gentilli S, Santori G, Stabilini C, Fornaro R, Frascio M. MicroRNAs differential expression profile in metastatic colorectal cancer: a pilot study with literature review. Surg Oncol. 2021;37:101524. doi:10.1016/j.suronc.2021.101524.
   PubMed Web of Science ®Google Scholar
• Dang HH, Ta HDK, Nguyen TTT, Anuraga G, Wang CY, Lee KH, Le NQK. Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation. Funct Integr Genomics. 2022;22(5):1057–1072. doi:10.1007/s10142-022-00883-3.
   PubMed Web of Science ®Google Scholar
• Dang HH, Ta HDK, Nguyen TTT, Anuraga G, Wang CY, Lee KH, Le NQK. Identifying GPSM family members as potential biomarkers in breast cancer: a comprehensive bioinformatics analysis. Biomedicines. 2021;9(9):1144. doi:10.3390/biomedicines9091144.
   PubMed Web of Science ®Google Scholar
• Yang L, Jing J, Sun L, Yue Y. Exploring prognostic genes in ovarian cancer stage-related coexpression network modules. Medicine. 2018;97(34):e11895. doi:10.1097/MD.0000000000011895.
   PubMed Web of Science ®Google Scholar
• Xu Y, Xu Y, Wang C, Xia B, Mu Q, Luan S, Fan J. Mining TCGA database for gene expression in ovarian serous cystadenocarcinoma microenvironment. PeerJ. 2021;9:e11375. doi:10.7717/peerj.11375.
   PubMed Web of Science ®Google Scholar
• Stronach EA, Cunnea P, Turner C, Guney T, Aiyappa R, Jeyapalan S, et al. The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma. Oncotarget. 2015;6(31):31593–31603.
   PubMedGoogle Scholar